737 related articles for article (PubMed ID: 9365887)
21. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
22. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
[TBL] [Abstract][Full Text] [Related]
23. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow.
Lundqvist A; Tolfvenstam T; Bostic J; Söderlund M; Broliden K
Scand J Infect Dis; 1999; 31(1):11-6. PubMed ID: 10381211
[TBL] [Abstract][Full Text] [Related]
24. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.
Larrañaga C; León O; Díaz P; Miranda M; Norambuena X; Pérez M; Gaggero A
J Med Virol; 2007 Dec; 79(12):1927-34. PubMed ID: 17935173
[TBL] [Abstract][Full Text] [Related]
25. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
Yazici AC; Aslan G; Baz K; Ikizoglu G; Api H; Serin MS; Tezcan S; Emekdas G; Tasdelen B
Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
[TBL] [Abstract][Full Text] [Related]
26. Human parvovirus B19 in cord blood of premature infants.
Koga M; Matsuoka T; Katayama K; Takeda K; Nakata M; Sase M; Kato H; Furukawa S
Am J Perinatol; 2001 Aug; 18(5):237-40. PubMed ID: 11552176
[TBL] [Abstract][Full Text] [Related]
27. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
28. [Secondary autoimmune hemolytic anemia as a result of B19 parvovirus persistence in immunodeficient patients].
Iaguzhinskaia OE; Fevraleva IS; Elizhbaeva MA; Levina AA; Semenova GM; Bugar' NIu; Tsybul'skaia LM; Varlamova EIu; Shitareva IV; Tsyba NI; Kravchenko SK
Ter Arkh; 2011; 83(12):62-8. PubMed ID: 22416448
[TBL] [Abstract][Full Text] [Related]
29. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
[TBL] [Abstract][Full Text] [Related]
30. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients.
Jordan J; Tiangco B; Kiss J; Koch W
Vox Sang; 1998; 75(2):97-102. PubMed ID: 9784661
[TBL] [Abstract][Full Text] [Related]
31. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
Banno S; Matsumoto Y; Sugiura Y; Ueda R
Ryumachi; 1997 Aug; 37(4):581-6. PubMed ID: 9311285
[TBL] [Abstract][Full Text] [Related]
32. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
[TBL] [Abstract][Full Text] [Related]
33. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
34. Human parvovirus Bb19 detection in asymptomatic blood donors: association with increased neopterin concentrations.
Schennach H; Lanthaler AJ; Mayersbach P; Ulmer H; Muell K; Schoenitzer D; Fuchs D; Larcher C
J Infect Dis; 2002 Nov; 186(10):1494-7. PubMed ID: 12404168
[TBL] [Abstract][Full Text] [Related]
35. Parvovirus B19 infection of bone marrow in systemic sclerosis patients.
Ferri C; Zakrzewska K; Longombardo G; Giuggioli D; Storino FA; Pasero G; Azzi A
Clin Exp Rheumatol; 1999; 17(6):718-20. PubMed ID: 10609071
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
37. Serological study of parvovirus B19 infection in women with recurrent spontaneous abortions.
Kishore J; Gupta I
Indian J Pathol Microbiol; 2006 Oct; 49(4):548-50. PubMed ID: 17183849
[TBL] [Abstract][Full Text] [Related]
38. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR.
Zaki SA
Indian J Med Microbiol; 2012; 30(4):407-10. PubMed ID: 23183464
[TBL] [Abstract][Full Text] [Related]
39. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
40. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.
Enders M; Weidner A; Rosenthal T; Baisch C; Hedman L; Söderlund-Venermo M; Hedman K
J Infect Dis; 2008 Jan; 197(1):58-62. PubMed ID: 18171285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
